EyePoint, Inc. (EYPT)
0.4045
-0.02
(-5.51%)
USD |
NASDAQ |
Oct 23, 16:00
0.413
+0.01
(+2.10%)
After-Hours: 20:00
EyePoint Market Cap : 34.38M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 34.38M |
| October 22, 2026 | 36.38M |
| October 21, 2026 | 36.54M |
| October 20, 2026 | 34.43M |
| October 19, 2026 | 37.39M |
| October 16, 2026 | 254.10M |
| October 15, 2026 | 266.84M |
| October 14, 2026 | 255.80M |
| October 13, 2026 | 260.89M |
| October 12, 2026 | 282.14M |
| October 09, 2026 | 288.94M |
| October 08, 2026 | 294.04M |
| October 07, 2026 | 282.14M |
| October 06, 2026 | 269.39M |
| October 05, 2026 | 267.69M |
| October 02, 2026 | 276.19M |
| October 01, 2026 | 274.49M |
| September 30, 2026 | 277.89M |
| September 29, 2026 | 290.64M |
| September 28, 2026 | 281.29M |
| September 25, 2026 | 307.63M |
| September 24, 2026 | 310.18M |
| September 23, 2026 | 316.13M |
| September 22, 2026 | 345.88M |
| September 21, 2026 | 341.63M |
| Date | Value |
|---|---|
| September 18, 2026 | 327.18M |
| September 17, 2026 | 339.08M |
| September 16, 2026 | 293.19M |
| September 15, 2026 | 311.03M |
| September 14, 2026 | 361.17M |
| September 11, 2026 | 359.47M |
| September 10, 2026 | 361.17M |
| September 09, 2026 | 368.82M |
| September 08, 2026 | 387.52M |
| September 04, 2026 | 389.22M |
| September 03, 2026 | 387.94M |
| September 02, 2026 | 407.06M |
| September 01, 2026 | 389.22M |
| August 31, 2026 | 382.42M |
| August 28, 2026 | 380.72M |
| August 27, 2026 | 393.47M |
| August 26, 2026 | 424.06M |
| August 25, 2026 | 425.33M |
| August 24, 2026 | 413.86M |
| August 21, 2026 | 452.10M |
| August 20, 2026 | 458.90M |
| August 19, 2026 | 535.39M |
| August 18, 2026 | 464.85M |
| August 17, 2026 | 413.86M |
| August 14, 2026 | 1.253B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocular Therapeutix, Inc. | 1.427B |
| Regeneron Pharmaceuticals, Inc. | 83.24B |
| Corcept Therapeutics, Inc. | 9.266B |
| Eli Lilly & Co. | 1.199T |
| Nuvation Bio, Inc. | 1.599B |
Market Cap Related Metrics
| PS Ratio | 11.81 |
| PEG Ratio | -0.0027 |
| Price to Book Value | 0.2066 |
| Price | 0.4045 |
| Earnings Yield | -925.5% |
| PEGY Ratio | -0.0027 |